- Home
- QNCX vs TPCS Comparison
QNCX vs TPCS Comparison
Compare QNCX & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- TPCS
- Stock Information
- Founded
- QNCX 2012
- TPCS 1956
- Country
- QNCX United States
- TPCS United States
- Employees
- QNCX N/A
- TPCS N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- TPCS Metal Fabrications
- Sector
- QNCX Health Care
- TPCS Industrials
- Exchange
- QNCX Nasdaq
- TPCS Nasdaq
- Market Cap
- QNCX 47.7M
- TPCS 42.6M
- IPO Year
- QNCX 2019
- TPCS N/A
- Fundamental
- Price
- QNCX $1.31
- TPCS $3.49
- Analyst Decision
- QNCX Strong Buy
- TPCS
- Analyst Count
- QNCX 5
- TPCS 0
- Target Price
- QNCX $8.00
- TPCS N/A
- AVG Volume (30 Days)
- QNCX 302.6K
- TPCS 29.2K
- Earning Date
- QNCX 08-12-2025
- TPCS 04-08-2025
- Dividend Yield
- QNCX N/A
- TPCS N/A
- EPS Growth
- QNCX N/A
- TPCS N/A
- EPS
- QNCX N/A
- TPCS N/A
- Revenue
- QNCX N/A
- TPCS $33,154,058.00
- Revenue This Year
- QNCX N/A
- TPCS N/A
- Revenue Next Year
- QNCX N/A
- TPCS N/A
- P/E Ratio
- QNCX N/A
- TPCS N/A
- Revenue Growth
- QNCX N/A
- TPCS 8.71
- 52 Week Low
- QNCX $0.51
- TPCS $2.05
- 52 Week High
- QNCX $2.45
- TPCS $4.42
- Technical
- Relative Strength Index (RSI)
- QNCX 64.64
- TPCS 45.47
- Support Level
- QNCX $1.29
- TPCS $3.21
- Resistance Level
- QNCX $1.45
- TPCS $3.43
- Average True Range (ATR)
- QNCX 0.09
- TPCS 0.21
- MACD
- QNCX 0.03
- TPCS -0.08
- Stochastic Oscillator
- QNCX 76.74
- TPCS 24.63
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.